Methodology

All entries for: Vitruviae Inc.

August 11, 2025

Vitruviae Inc.

Orphan Drug Designation

FDA orphan drug designation: treatment of acute myeloid leukemia

Disease Area: Rare Diseases
Source
Facebook Linkedin
Main Menu
Scroll to Top